LEHI, UTAH / ACCESSWIRE / November 12, 2019 / Frelii, Inc. (OTC PINK:FRLI) ("Frelii" or the "Company"), a biotechnology company working to commercialize its patent-pending DNA gene sequencing ...
Clinuvel Pharmaceuticals revealed Prénumbra the company’s second afamelanotide product in development. Prénumbra is a liquid (non-solid) formulation of afamelanotide to be evaluated by Clinuvel in ...
Study published in Molecular Therapy found factors affecting pharmacodynamics and described stability. Alnylam Pharmaceuticals and researchers from the Massachusetts Institute of Technology (MIT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback